Skip to content

Study of Endoscopic Barrett's Esophagus Diagnosis

A Prospective Study on the Interobserver Agreement of Endoscopic Barrett's Esophagus

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00591461
Enrollment
13
Registered
2008-01-11
Start date
2007-12-31
Completion date
2010-03-31
Last updated
2019-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett's Esophagus, GERD

Keywords

Barrett's Esophagus, Upper Endoscopy, Esophageal biopsies, Accuracy, Interobserver Agreement

Brief summary

Barrett's esophagus (BE) is a condition that often occurs in patients who have had GERD for a long time. The researchers are interested in BE because it can sometimes become a cancer in the esophagus. The way that we currently diagnose BE is by performing an upper endoscopy and looking for a change in the color of the esophagus. This color change may represent BE. If the doctor sees this, he/she may take biopsies of this area. Studies have shown that making the diagnosis of BE can be hard to make. One of the reasons why this may be is because doctors may interpret what they see differently during the procedure. In other words, they may see an esophagus that appears normal in color or abnormal in color. The purpose of this study is to compare two doctors' impressions of the appearance of the esophagus during a single endoscopy procedure.

Interventions

None listed

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* History of (h/o) GERD * Upper GI symptoms such as acid taste in mouth, dysphagia, dyspepsia * Screening or surveillance exam for BE

Exclusion criteria

* Unable to consent * History of esophageal varices

Design outcomes

Primary

MeasureTime frame
The primary outcome will be the interobserver variability in the presence of columnar epithelium as well as the measured lengths.one endoscopy visit

Secondary

MeasureTime frame
frequency of pathology-confirmed BEone endoscopy visit
variables that predict endoscopic interobserver agreement and path-confirmationone endoscopy visit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026